Grant received in 2020
DCCC has funded 200,000 DKKK to the preparation of this national and multidisciplinary investigator-initiated study.
Promising results with Car T-cells have been found among patients with lymphoma. Car T-treatment is where one takes the patient's own cells and "train" them to attack cancer cells. This preliminary work consists of investigating if it is possible to enhance effect and diminish side effects of Car T-treatment by giving radiotherapy instead of chemotherapy the first 2-4 months, where the cells develop. The initiation of the study will give patients without current alternative treatments access to Car T-treatment, which is unviable in Denmark, presently.
Multidisciplinary organisation
Study preparations are anchored in Danish Lymphoma Group and done in collaboration with Nordic Lymphoma Group and DALROG (Danish Lymphoma Radiation Oncology Group) and with participation from all four treatment facilities in Denmark.
Project stakeholders
- Judit Mészáros Jørgensen, Consultant, PhD, Department of Haematology, Aarhus University Hospital, Member of Danish Lymphoma Group. Primary contact, mail: judit.joergensen@aarhus.rm.dk
- Christian Bjørn Poulsen, Consultant, PhD., Department of Haematology, Roskilde University Hospital
- Michael Pedersen, Consultant, Department of Haematology, Rigshospitalet
- Pär Lars Josefsson, Consultant, PhD, Department of Haematology, Herlev Hospital
- Thomas Stauffer Larsen, Consultant, PhD., Department of Haematology, Odense University Hospital
- Jørn Starklint, Consultant, PhD, Department of Haematology, Holstebro Hospital
- Jakob Madsen, Consultant, Department of Haematology, Aalborg University Hospital
- Andriette Dessau-Arp, specialty Registrar, Department of Haematology, Esbjerg Hospital
- Erik Clasen-Linde, Consultant, Department of Haematology, Rigshospitalet
- Peter Kamper, Consultant, PhD, Department of Haematology, Aarhus University Hospital
- Michael Roost Clausen, Consultant, PhD, Department of Haematology, Vejle Hospital
- Peter de Nully Brown, Consultant, PhD, Department of Haematology, Rigshospitalet
- Per Boye Hansen, Consultant, PhD, Department of Haematology, Roskilde University Hospital
- Anne Ortved Gang, Consultant, PhD, Department of Haematology, Herlev Hospital
- Lena Specht, Professor, Consultant, DMSc., Department of Oncology, Rigshospitalet
- Eva Holtved, Consultant, PhD, Department of Oncology, Odense University Hospital
- Christian Maare, Consultant, PhD, Department of Oncology, Herlev Hospital
- Tamás Lörincz, Consultant, PhD, Department of Oncology, Aalborg University Hospital
- Hanne Krog Rose, Consultant, PhD, Department of Oncology, Aarhus University Hospital
- Mette Skytte Tetsche, Consultant, PhD, Department of Oncology, Aarhus University Hospital
- Francesco d´Amore, professor, DMSc., Department of Haematology, Aarhus University Hospital
- Maja Ludvigsen, cand. scient., PhD, Associate professor, Department of Haematology, Aarhus University Hospital
- Sirpa Leppä, Professor, DMSc, Department of Oncology, Helsinki University, Central Hospital Helsinki, Finland
- Kristina Drott, Consultant, PhD, Department of Oncology, Lund University Hospital, Lund, Sweden
- Harald Holte, Consultant DMSc., Department of Oncology, Oslo University Hospital, Oslo, Norway
- Per-Ola Andersson, Consultant, PhD, Department of Medicine, Karolinska Hospital, Stockholm, Sweden
- Öystein Fluge, Consultant, PhD, Department of Oncology, Haukeland University Hospital, Bergen, Norway
News
DCCC Strengthens Danish Cancer Research With 1.7 Million DKK, November 27, 2020